Sigilon Therapeutics, Inc.
SGTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $107 | $202 | $76 |
| Short-Term Investments | $28 | $16 | $0 | $0 |
| Receivables | $3 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $2 | $1 |
| Total Curr. Assets | $74 | $126 | $204 | $77 |
| Property Plant & Equip (Net) | $12 | $17 | $20 | $13 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $13 | $18 | $21 | $13 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $87 | $144 | $225 | $90 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $2 |
| Short-Term Debt | $11 | $7 | $5 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $13 | $17 | $32 | $29 |
| Other Curr. Liab. | $6 | $9 | $8 | $6 |
| Total Curr. Liab. | $31 | $35 | $47 | $40 |
| LT Debt | $17 | $27 | $32 | $22 |
| Deferred Rev, NC | $0 | $5 | $0 | $16 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $91 |
| Total NC Liab. | $17 | $32 | $32 | $128 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $48 | $67 | $79 | $168 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $225 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$257 | -$213 | -$136 | -$81 |
| AOCI | -$0 | -$0 | -$225 | $0 |
| Other Equity | $296 | $290 | $282 | $4 |
| Total Equity | $39 | $77 | $146 | -$78 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $87 | $144 | $225 | $90 |
| Net Debt | -$14 | -$74 | -$165 | -$51 |